sk life science inc
SK Biopharmaceuticals Initiates PhII Trial For Diabetic Peripheral Neuropathy Drug
South Korean pharmaceutical company SK Biopharmaceuticals has initiated a Phase II trial in the United States for its new diabetic peripheral neuropathy drug, SKL11197.